Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
<h4>Background</h4>Increasing the diversity of research participants is an important focus of clinical trials. However, little is known regarding who enrolls as healthy volunteers in Phase I clinical trials, which test the safety and tolerability of investigational new drugs. Despite the...
Main Authors: | Corey A Kalbaugh, Julianne M Kalbaugh, Lisa McManus, Jill A Fisher |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0256994 |
Similar Items
-
Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
by: Jill A Fisher, et al.
Published: (2018-11-01) -
Correction: Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
by: PLOS ONE Staff
Published: (2022-01-01) -
Correction: Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time
by: The Staff
Published: (2022-01-01) -
United States private-sector physicians and pharmaceutical contract research: a qualitative study.
by: Jill A Fisher, et al.
Published: (2012-01-01) -
Awareness of Clinical Trials Participation among Healthy Volunteers
by: Yusof, Yuhanif, et al.
Published: (2020)